Ginkgo Biloba: Benefits, Forms, Dosing, and Side Effects

Ginkgo biloba is one of the oldest living tree species on earth, commonly referred to as a "living fossil." It is the sole surviving member of the family Ginkgoaceae, a primitive plant lineage dating back over 200 million years [1][2]. The tree has a long history of use in traditional Chinese medicine for treating cough, diarrhea, and other conditions [2]. Today, ginkgo leaf extract is one of the most widely consumed herbal supplements worldwide, promoted for cognitive enhancement, memory support, circulation, tinnitus, anxiety, and a range of other conditions [1][2][3].

Ginkgo dietary supplements are made from the leaves of the Ginkgo biloba tree and contain a variety of phytochemicals, most notably flavonol glycosides and terpene lactones [1]. The dried, powdered leaves are sometimes used in supplements, although virtually all clinical studies have used standardized extracts [1]. The extraction process concentrates the active compounds to approximately 50 times the concentration found in the raw leaf, and it also removes impurities including heavy metals and potentially toxic ginkgolic acids [1][4].

Despite its widespread use and long history, the clinical evidence for ginkgo biloba is largely disappointing. The National Center for Complementary and Integrative Health (NCCIH) concludes that "there's no conclusive evidence that ginkgo is helpful for any health condition" [2]. Multiple large, well-designed randomized controlled trials — including studies with over 3,000 participants followed for up to six years — have failed to demonstrate that ginkgo prevents dementia, slows cognitive decline, or meaningfully improves memory in healthy adults [1][2][3]. However, some evidence supports modest benefits for specific conditions including vertigo, peripheral vascular disease, and diabetic neuropathy [1].

This article reviews the complete clinical evidence for ginkgo biloba, covering all studied conditions, dosing protocols, safety considerations, drug interactions, and practical guidance for consumers considering this supplement.

Table of Contents

• Overview
• Forms and Bioavailability
• Evidence for Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Dietary Sources
• References

Overview

Ginkgo biloba is one of the oldest living tree species on earth, commonly referred to as a "living fossil." It is the sole surviving member of the family Ginkgoaceae, a primitive plant lineage dating back over 200 million years [1][2]. The tree has a long history of use in traditional Chinese medicine for treating cough, diarrhea, and other conditions [2]. Today, ginkgo leaf extract is one of the most widely consumed herbal supplements worldwide, promoted for cognitive enhancement, memory support, circulation, tinnitus, anxiety, and a range of other conditions [1][2][3].

Ginkgo dietary supplements are made from the leaves of the Ginkgo biloba tree and contain a variety of phytochemicals, most notably flavonol glycosides and terpene lactones [1]. The dried, powdered leaves are sometimes used in supplements, although virtually all clinical studies have used standardized extracts [1]. The extraction process concentrates the active compounds to approximately 50 times the concentration found in the raw leaf, and it also removes impurities including heavy metals (lead, cadmium, arsenic) and potentially toxic ginkgolic acids [1][4].

The most extensively studied ginkgo extract is EGb 761 (Schwabe Pharmaceuticals), standardized to contain 24% flavonol glycosides and 6% terpene lactones [1][4]. These flavonol glycosides include quercetin, kaempferol, and isorhamnetin, while the terpene lactones include ginkgolides A, B, and C, and bilobalide [1][4]. These active compounds are believed to exert their effects through several mechanisms: increasing cerebral and peripheral blood flow, scavenging free radicals, reducing platelet aggregation, modulating neurotransmitter systems, and reducing inflammation [1][2][3].

Despite its widespread use and long history, the clinical evidence for ginkgo biloba is largely disappointing. The National Center for Complementary and Integrative Health (NCCIH) concludes that "there's no conclusive evidence that ginkgo is helpful for any health condition" [2]. Multiple large, well-designed randomized controlled trials — including studies with over 3,000 participants followed for up to six years — have failed to demonstrate that ginkgo prevents dementia, slows cognitive decline, or meaningfully improves memory in healthy adults [1][2][3]. However, some evidence supports modest benefits for specific conditions including vertigo, peripheral vascular disease, and diabetic neuropathy, though even these findings come from small or industry-funded studies [1].

This article reviews the complete clinical evidence for ginkgo biloba, covering all studied conditions, dosing protocols, safety considerations, drug interactions, and practical guidance for consumers considering this supplement.

Forms and Bioavailability

Standardized Extracts vs. Raw Leaf

The distinction between ginkgo leaf extract (GBE) and raw dried ginkgo leaf is critical. Clinical studies have exclusively used standardized extracts, not dried leaf powder [1]. The extraction process concentrates the active phytochemicals approximately 50-fold compared to the raw leaf, making extracts far more potent per milligram [1].

Contamination with lead, cadmium, and arsenic is uncommon with extracts, as the extraction and purification process removes these impurities [1][4]. Additionally, ginkgolic acids — compounds with sensitizing, mutagenic, and potentially carcinogenic effects in laboratory studies — are greatly reduced during extraction [4]. Consumers seeking products most similar to those used in clinical trials should choose standardized ginkgo leaf extracts rather than raw leaf preparations [1].

EGb 761: The Clinical Standard

The most studied ginkgo extract is EGb 761, manufactured by Schwabe Pharmaceuticals (also marketed as Tebonin and Tanakan in some countries). It is standardized to contain [1][4]:

• 24% flavonol glycosides (total) — Quercetin: minimum 9.5%, Kaempferol: minimum 10.5%, Isorhamnetin: minimum 2.0%
• 6% terpene lactones (total) — Ginkgolides A, B, C: minimum 2.8%, Bilobalide: minimum 2.6%
• Ginkgolic acids: less than 5 ppm (parts per million)

These specifications define the quality standard against which all ginkgo supplements should be measured. Products labeled as "24/6" (24% flavonol glycosides, 6% terpene lactones) are attempting to match this profile, though the specific sub-fractions (quercetin, kaempferol, ginkgolide ratios) are rarely listed on labels [1].

Other Studied Extracts

Two other ginkgo preparations have been used in clinical trials, though far less extensively than EGb 761 [1]:

• LI 1370: A standardized extract with a similar phytochemical profile to EGb 761. Used in some European studies on cognitive function [5].
• Blackmore's Ginkgo: An Australian proprietary extract used in a limited number of trials on memory in healthy adults [5].

Combination Products

Some supplements combine ginkgo with other ingredients. One example studied clinically is Nutrilite Memory Builder (Amway), which combines 60 mg of ginkgo biloba leaf extract with 150 mg of Cistanche tubulosa root extract per tablet [6]. However, combination products make it difficult to attribute effects specifically to ginkgo, and the evidence for these formulations is limited to single, manufacturer-funded studies [6].

Bioavailability Considerations

The flavonol glycosides in ginkgo extracts are absorbed in the gastrointestinal tract and reach peak plasma concentrations within 1-3 hours after oral administration [3]. The terpene lactones (ginkgolides and bilobalide) are also well absorbed orally [3]. The elimination half-life of the major active compounds ranges from approximately 3-10 hours, which is the basis for the common recommendation to split the daily dose into two or three administrations throughout the day [1][3].

Summary Table: Ginkgo Supplement Forms

Form	Clinical Evidence	Active Compound Concentration	Safety Profile
Standardized leaf extract (24/6)	Extensive (EGb 761)	50x raw leaf	Well-characterized; low ginkgolic acids
Raw dried leaf powder	None	Low (~1/50th of extract)	Higher ginkgolic acid content; heavy metal risk
Ginkgo fruit/seed	Not used in supplements	Different compound profile	Toxic; can cause contact dermatitis, GI symptoms
Combination products	Very limited	Variable	Depends on co-ingredients

Evidence for Benefits

Alzheimer's Disease and Dementia

Ginkgo biloba leaf extract has been one of the most widely studied natural products for cognitive decline, dementia, and Alzheimer's disease. The rationale is based on ginkgo's ability to increase cerebral blood flow, reduce oxidative stress, and modulate neurotransmitter activity [1][2][3]. However, the two largest and most rigorous trials have been definitively negative.

The GEM Study (Ginkgo Evaluation of Memory): This was the landmark trial — the largest randomized controlled trial of ginkgo ever conducted. Funded by the National Institutes of Health (NCCIH and National Institute on Aging), the GEM study enrolled 3,069 community-dwelling adults aged 75 or older with either normal cognitive function or mild cognitive impairment. Participants were randomized to receive 120 mg of EGb 761 twice daily (240 mg/day total) or placebo for a median follow-up of 6.1 years. The primary outcome was the incidence of all-cause dementia [7].

Results: Ginkgo had no effect on preventing dementia of any type or Alzheimer's disease specifically. The rate of dementia was 3.3 per 100 person-years in the ginkgo group versus 2.9 per 100 person-years in the placebo group — numerically slightly worse, though not statistically significant (HR 1.12, 95% CI: 0.94-1.33, P=0.21) [7]. A subsequent analysis of the same study population found that ginkgo also failed to slow cognitive decline: there was no significant difference between groups in the rate of change on any cognitive test, including the Modified Mini-Mental State Examination (3MSE) and the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) [8].

The GuidAge Study: This was a large French randomized controlled trial involving 2,854 individuals aged 70 or older who had reported memory complaints to their doctor. Participants received 120 mg of EGb 761 twice daily (240 mg/day) or placebo for five years. The primary outcome was conversion to Alzheimer's disease [9].

Results: Ginkgo extract did not reduce the risk of progression to Alzheimer's disease compared with placebo. The hazard ratio was 0.84 (95% CI: 0.60-1.18, P=0.306), indicating no statistically significant benefit [9].

Cochrane Review: A comprehensive Cochrane review of over 30 clinical trials found "inconsistent and unconvincing" evidence that ginkgo had benefits for individuals with dementia or cognitive impairment [1][10]. While some individual trials (often small and industry-funded) showed modest effects on cognitive test scores, the overall body of evidence did not support a meaningful clinical benefit.

Meta-analysis of treatment: A meta-analysis by Liao et al. (Clinical Neuropharmacology, 2020) examined ginkgo biloba preparation for the treatment of Alzheimer's disease and found some positive signals in smaller trials, but the NCCIH notes that the evidence remains inconsistent, particularly at the high-quality trial level [3][11].

Synthesis: On the whole, current evidence indicates no significant benefit for ginkgo in preventing or treating Alzheimer's disease or other dementias [1][2]. The two largest, most methodologically rigorous trials (GEM and GuidAge) — together involving nearly 6,000 participants followed for 5-6 years — were both clearly negative. Smaller positive trials tend to be short-term, industry-funded, and subject to publication bias.

Memory and Cognitive Function in Healthy Adults

For healthy individuals seeking cognitive enhancement, the evidence for ginkgo is weak and inconsistent.

Positive evidence (small, industry-funded): A 6-week study of 240 mg EGb 761 once daily in healthy middle-aged adults, funded by Schwabe Pharmaceuticals, found that ginkgo improved memory recall (specifically, recall of a detailed list of appointments) compared to placebo. However, it did not improve recognition memory (of a driving route), nor did it improve self-perceived mood or well-being [1][12].

Systematic review (negative): A review of 10 short-term studies in healthy individuals found no significant positive effects on memory, executive function, or attention [5]. The studies included EGb 761 and two similar preparations (LI 1370 and Blackmore's), and the overall conclusion was that ginkgo does not reliably enhance cognitive performance in healthy adults.

Combination product study: A study among 92 healthy men and women ages 40-75 in China tested a ginkgo-containing combination product (containing 60 mg ginkgo + 150 mg Cistanche tubulosa per tablet, two tablets daily) for three months. The ginkgo combination showed minimal cognitive benefits: total scores on the Wechsler Memory Scale-Revised increased by just 6.5 points (on a 0-200 scale) compared to no change in the placebo group, and MMSE scores improved by only 0.4 points (on a 0-30 scale) — a change too small to be clinically meaningful [6].

Interestingly, blood levels of total tau protein (higher levels of which can indicate increased risk of Alzheimer's disease) fell by approximately 21% in the supplement group versus little change in the placebo group, after adjusting for age, gender, and body mass. Whether this biomarker change translates to meaningful long-term protection remains unknown. The study was funded by Amway, and most researchers were company employees [6].

Self-reported memory impairment: A study funded by the makers of EGb 761 examined 60 men and women with self-reported memory impairment who took 240 mg of EGb 761 once daily for two months. The extract modestly improved cognitive flexibility (the ability to transition between tasks or concepts) but did not improve attention or prospective memory (remembering to perform a planned future task) compared to placebo [13].

Systematic review of cognitive supplements: Crawford et al. (Journal of Alternative and Complementary Medicine, 2021) conducted a systematic review of dietary supplement ingredients for optimizing cognitive performance among healthy adults and found that the evidence for ginkgo was insufficient to support a recommendation [14].

NCCIH position: Although dietary supplements containing ginkgo have been marketed for "brain health," it remains uncertain whether they actually influence cognitive performance in healthy people. Much of the research on this topic is of low quality [2].

Synthesis: The evidence for ginkgo as a cognitive enhancer in healthy adults is weak. The small positive effects observed in some trials are limited to narrow cognitive domains, come from short-duration industry-funded studies, and are not supported by higher-quality systematic reviews. Ginkgo should not be relied upon for meaningful cognitive enhancement.

Vertigo and Dizziness

Vertigo is one of the conditions with the strongest (though still limited) evidence favoring ginkgo.

Primary trial: In a clinical study of people with vertigo, 47% of those who took 160 mg of ginkgo biloba extract daily for 3 months completely recovered, compared with only 18% of those taking a placebo. This represents a relative recovery rate approximately 2.6 times higher with ginkgo [1][15].

Vestibular disorders: A dose of 80 mg of ginkgo biloba taken twice daily (160 mg/day total) has been shown to reduce vertigo and dizziness associated with certain vestibular disorders [1][16].

NCCIH assessment: The NCCIH acknowledges that "a small amount of evidence suggests a benefit from taking ginkgo orally" for vertigo, but notes that "the overall evidence is not conclusive" [2].

Synthesis: Vertigo appears to be one of the more promising indications for ginkgo, with two clinical trials showing meaningful improvements at doses of 160 mg/day over 3 months. However, both studies are relatively old, small, and the evidence base is not as robust as would be ideal.

Tinnitus

Ginkgo has been widely promoted for tinnitus (ringing in the ears) based on evidence from human, animal, and in vitro studies showing that ginkgo may increase blood flow, reduce free radical damage, improve nerve function, and reduce inflammation [1]. However, clinical evidence does not support this use.

Cochrane Review: A comprehensive analysis of 12 clinical studies involving 1,915 people with tinnitus found that taking 120 mg of ginkgo biloba extract daily for 3-6 months did not significantly reduce tinnitus symptom severity compared to placebo. It also did not significantly reduce tinnitus loudness or improve health-related quality of life [17].

Post-Cochrane study: A study published after the Cochrane review, involving 69 people with tinnitus in India, also found that 60 mg of ginkgo twice daily (120 mg/day) for 12 weeks did not reduce tinnitus symptom severity or improve overall health compared to placebo. There was a slight improvement in the subgroup of participants who, in addition to ginkgo, took a supplement containing multiple antioxidants (20 mg beta-carotene, 200 mg vitamin C, 200 mg vitamin E, and 50 mcg selenium), though this finding should be interpreted cautiously given the subgroup analysis [18].

Expert opinion: Some experts now advise against the use of ginkgo to treat tinnitus due to the lack of quality evidence [19].

NCCIH position: Research suggests that ginkgo is not helpful for relieving symptoms of tinnitus [2].

Synthesis: Despite its popularity as a tinnitus remedy, ginkgo biloba has been thoroughly studied for this condition and found to be ineffective. A Cochrane review of 12 trials with nearly 2,000 participants found no significant benefit for tinnitus severity, loudness, or quality of life. This is one of the clearest negative findings in the ginkgo literature.

Peripheral Vascular Disease and Intermittent Claudication

Ginkgo has been used for reducing pain while walking in people with intermittent claudication — a condition caused by peripheral artery disease that causes cramping leg pain during exercise due to insufficient blood flow [1].

The rationale is sound (ginkgo's antiplatelet and vasodilatory effects could theoretically improve peripheral circulation), and some early clinical trials showed modest increases in pain-free walking distance [1]. The typical dose studied for this indication was 120-240 mg/day of standardized ginkgo extract [1]. However, the magnitude of benefit in available trials has been small, and larger, higher-quality trials are lacking. The evidence is considered insufficient to recommend ginkgo over established treatments for peripheral vascular disease [2][3].

Raynaud's Disease

One small study examined 22 men and women with Raynaud's disease who received 120 mg of ginkgo biloba extract three times daily (total daily dose: 360 mg) or placebo for two months. The ginkgo group experienced a reduction in the average weekly number of self-reported attacks from 13.2 to 5.8, compared with a reduction from 13.6 to 10.0 in the placebo group. However, ginkgo did not decrease the severity or duration of the attacks [20].

A single small trial suggests ginkgo may reduce the frequency (but not severity) of Raynaud's attacks at a relatively high dose of 360 mg/day. This is far from conclusive, and the finding requires replication in larger studies.

Diabetic Neuropathy

A small study among 134 people with diabetic sensorimotor polyneuropathy (a type of nerve damage caused by diabetes) showed that taking 120 mg of EGb 761 once daily after breakfast for 6 months reduced neuropathic pain by 6.95 points (on a 45-point total scale) compared to an increase of 1.22 points in the placebo group [21].

Based on results from this study, the 2021 guidelines published by the American Academy of Neurology state that ginkgo "might be more likely to improve pain than placebo" in diabetic neuropathy [22]. This represents a cautious but notable endorsement from a major medical society.

This is one of the more encouraging findings for ginkgo. A single trial showed clinically meaningful pain reduction in diabetic neuropathy, and the American Academy of Neurology incorporated this into their guidelines. However, the evidence rests on a single study with a modest sample size, and replication is needed before strong recommendations can be made.

Anxiety

A systematic review and network meta-analysis of medicinal herbs for anxiety treatment found that ginkgo biloba was among the herbs with some evidence of anxiolytic effects, though the overall evidence was limited and the NCCIH notes that only "a small amount of evidence suggests a benefit" [2][23].

Other Conditions

Stroke rehabilitation: The NCCIH notes that ginkgo "might also be helpful in the rehabilitation of patients who have had strokes," though the evidence is preliminary and the benefit remains unconfirmed [2].

Premenstrual syndrome (PMS): Ginkgo has been studied for PMS symptoms at a dose of 80 mg twice daily, beginning on day 16 of the current menstrual cycle and continuing until day 5 of the next cycle [1]. Some evidence suggests modest benefit for physical and psychological PMS symptoms, but the trials are small and the evidence is considered inconclusive [2].

Glaucoma: Ginkgo has been investigated for normal-tension glaucoma, with the rationale that improved ocular blood flow could protect the optic nerve. The dose typically studied was 120 mg/day. Results from small trials suggest possible benefit, but the evidence is preliminary and insufficient for clinical recommendations.

Conditions Where Ginkgo Is Ineffective

Clinical studies have found ginkgo to be clearly ineffective for several conditions:

• Altitude sickness prevention: Clinical studies found ginkgo ineffective [1]
• Heart disease prevention: Research suggests ginkgo is not helpful [2]
• High blood pressure treatment: Ginkgo is not helpful for treating high blood pressure [2]
• Multiple sclerosis symptoms: Research suggests ginkgo is not helpful [2]

Summary of Evidence by Condition

Condition	Evidence Level	Direction	Key Finding
Dementia/Alzheimer's prevention	High (large RCTs)	Negative	No benefit in 6,000+ participants over 5-6 years [7][8][9]
Dementia/Alzheimer's treatment	Moderate	Mixed/Negative	Inconsistent; Cochrane review found evidence "unconvincing" [10]
Memory in healthy adults	Moderate	Negative	Systematic review of 10 trials found no benefit [5]
Vertigo	Low-Moderate	Positive	47% vs 18% recovery at 160 mg/day for 3 months [15]
Tinnitus	High (Cochrane)	Negative	No benefit in 12 trials, 1,915 participants [17]
Diabetic neuropathy	Low	Positive	Pain reduction; AAN guideline mention [21][22]
Raynaud's disease	Very Low	Positive	Fewer attacks at 360 mg/day in one small trial [20]
Intermittent claudication	Low-Moderate	Weakly Positive	Small increases in walking distance [1]
PMS	Very Low	Weakly Positive	Some symptom relief in small trials [1]
Altitude sickness	Low	Negative	Ineffective [1]
Anxiety	Very Low	Weakly Positive	Limited evidence of anxiolytic effects [23]

Recommended Dosing

Standard Dosing by Condition

Dosing recommendations are based on the amounts used in clinical trials. Note that the evidence for most conditions is weak or negative, so these doses reflect what was studied rather than proven effective [1].

Condition	Daily Dose	Division	Duration Studied
Dementia/Alzheimer's (prevention or treatment)	120-240 mg	120 mg twice daily or 240 mg once daily	3 months to 6 years
Memory function (healthy adults)	240 mg	Once daily	6 weeks to 3 months
Cognitive function (general)	120-600 mg	Divided into 2-3 doses	Varies
Vertigo	120-160 mg	Divided into 2 doses or once daily	3 months
Intermittent claudication	120-240 mg	Divided into 2-3 doses	3-6 months
Raynaud's disease	360 mg	120 mg three times daily	2 months
Normal-tension glaucoma	120 mg	Divided into 2 doses	3+ months
PMS	160 mg	80 mg twice daily (cycle day 16 to day 5)	Cyclic use
Diabetic neuropathy	120 mg	Once daily (after breakfast)	6 months

Practical Dosing Guidance

Extract quality matters more than dose. Consumers should select products standardized to 24% flavonol glycosides and 6% terpene lactones — the profile matching EGb 761 used in the major clinical trials [1][4]. Although product labels rarely list the specific sub-fractions (quercetin, kaempferol, isorhamnetin, individual ginkgolides), the 24/6 standardization is the minimum quality marker [1].

Splitting the daily dose is common practice. The 3-10 hour elimination half-life of ginkgo's active compounds supports dividing the total daily dose into 2-3 administrations for more stable blood levels throughout the day [1][3]. However, several studies (particularly for memory in healthy adults) have used a single daily dose of 240 mg with comparable results [1][12].

Duration matters. Most positive findings in clinical trials emerged after at least 3 months of consistent use. Short-term use (days to weeks) is unlikely to produce meaningful effects based on available evidence [1].

Ginkgo leaf extract, not raw leaf. Products should contain ginkgo leaf extract (GBE), not dried powdered leaf. The active compounds are approximately 50 times more concentrated in extracts [1]. Dried leaf products are untested in clinical trials and may contain higher levels of ginkgolic acids [4].

Safety and Side Effects

General Safety Profile

For most adults, ginkgo leaf extracts appear to be safe when taken orally in moderate amounts [2][4]. Standardized ginkgo extracts have been used safely in research studies lasting as long as 6 years, including the GEM trial involving over 3,000 participants [2][7].

The most common side effects are generally mild [2][4]:

• Dizziness
• Gastrointestinal symptoms (nausea, stomachache)
• Headache
• Nervousness (particularly at high doses)

Bleeding Risk

Ginkgo may increase the risk of bleeding due to its antiplatelet effects [2][3][4]. Important precautions include:

• Bleeding disorders: People with bleeding disorders, or who have had a stroke or are at risk for a stroke, should avoid ginkgo [4].
• Surgery: Stop taking ginkgo products at least 2 weeks before planned surgeries. Ginkgo might increase the risk of bleeding complications during and after surgery [4].
• Anticoagulant medications: Ginkgo may increase the risk of bleeding when combined with blood-thinning medications [2][4].

A review by Hatfield et al. (Proceedings of Baylor University Medical Center, 2022) documented ginkgo among dietary supplements associated with clinically significant bleeding events [24].

Dermatologic Reactions

Although rare, several types of skin reactions have been reported [4]:

• Contact dermatitis: Ginkgo biloba fruit can cause contact dermatitis following topical exposure [25]. Note: ginkgo fruit is not typically used in dietary supplements, but cross-reactivity is possible.
• Fixed drug eruption: A case report described a 36-year-old man who developed itchiness and redness after taking a ginkgo biloba supplement. Symptoms resolved upon discontinuation and recurred upon rechallenge — classic for a fixed drug eruption [27].
• Stevens-Johnson syndrome: A case of this severe skin reaction appears to have occurred due to ingestion of a ginkgo biloba extract [28]. This is exceptionally rare but potentially life-threatening.

Hyponatremia (Low Sodium)

Although uncommon, more than twenty cases of low sodium levels in the blood (hyponatremia) associated with ginkgo use have been reported to the World Health Organization [4]. Symptoms may include nausea, headache, confusion, and fatigue. Two additional cases were reported in New Zealand involving a 70-year-old man and a 66-year-old woman who developed low sodium after taking ginkgo daily for 3-6 weeks. The condition resolved after stopping supplementation [29].

Blood Sugar Effects

People with diabetes should be aware that ginkgo can alter blood sugar levels and may affect responses to blood sugar-lowering medications [4]. This effect should be monitored, particularly in patients on insulin or oral hypoglycemic agents.

Fertility Concerns

Couples trying to conceive, especially those who have had difficulty conceiving, should avoid ginkgo-containing products. Laboratory and animal studies suggest ginkgo might interfere with fertilization and conception [4].

Pregnancy and Breastfeeding

Ginkgo may be unsafe for use during pregnancy. It might cause early labor or extra bleeding during delivery if used near that time [2]. There is a lack of evidence for the effectiveness and safety of ginkgo in women who are pregnant or nursing [4][30]. Little is known about whether it is safe to use ginkgo while breastfeeding [2].

Cancer Concerns from Animal Studies

A toxicology study by the U.S. National Toxicology Program (NTP, 2013) found that a ginkgo extract caused cancers of the thyroid gland in male and female rats and male mice, as well as cancers of the liver in male and female mice, when given five times per week for two years [4][31]. However, the dose given per kilogram of body weight averaged several hundred times the amount normally taken by people, and no epidemiological evidence has linked ginkgo supplement use to cancer in humans [4].

Ginkgolic Acids

Ginkgo leaves and seeds contain ginkgolic acids known to produce sensitizing, mutagenic, and carcinogenic effects in vitro [32]. However, the concentration of ginkgolic acids is greatly reduced in standardized ginkgo extracts due to purification steps. Products standardized to the EGb 761 specification limit ginkgolic acids to less than 5 ppm [4].

Fresh Ginkgo Seeds: A Distinct Hazard

Fresh ginkgo seeds are toxic when consumed orally, and serious side effects — including seizures and death — have occurred in people who consumed raw ginkgo seeds or the crude ginkgo plant [2]. Roasted ginkgo seeds can also cause adverse reactions. This is a distinct hazard from ginkgo leaf extract supplements [2].

Drug Interactions

Ginkgo biloba has pharmacologically significant interactions with several classes of medications due to its antiplatelet, vasodilatory, and enzyme-modulating effects [2][3][4].

Anticoagulants and Antiplatelet Agents

Drug	Interaction	Clinical Significance
Warfarin (Coumadin)	Ginkgo may potentiate anticoagulant effect	Potentially serious; may increase bleeding risk [2][4]
Aspirin	Additive antiplatelet effects	Case reports of spontaneous bleeding [4]
Clopidogrel (Plavix)	Additive antiplatelet effects	Increased bleeding risk [3]
Other NSAIDs	Additive effects on bleeding time	Use with caution [4]

Warfarin interaction is the most clinically significant. FDA safety labeling and warfarin prescribing information specifically warn about concomitant ginkgo use [4].

Anti-Seizure Medications

Ginkgo might increase the risk of seizures in people with epilepsy and reduce the effectiveness of anti-seizure drugs [4]. The mechanism may involve ginkgotoxin (4'-O-methylpyridoxine), a naturally occurring compound in ginkgo that can inhibit GABA synthesis. While the amount in standardized extracts is small, this interaction is clinically significant for people with seizure disorders [3][4].

Blood Sugar-Lowering Medications

Ginkgo can alter blood glucose levels and may interfere with responses to insulin, metformin, sulfonylureas, and other glucose-lowering agents [4]. Patients with diabetes who take ginkgo should monitor blood glucose more frequently.

Cytochrome P450 Interactions

Ginkgo biloba can affect hepatic drug metabolism through the cytochrome P450 system [3]. Ginkgo may induce CYP3A4, potentially reducing plasma levels of drugs metabolized by this enzyme (e.g., some statins, calcium channel blockers, immunosuppressants). Some evidence also suggests inhibition of CYP2C19, which could increase levels of drugs like omeprazole and clopidogrel.

A review by Czigle et al. (PeerJ, 2023) documented the pharmacokinetic and pharmacodynamic herb-drug interactions of ginkgo and other herbal medicines of the central nervous system, confirming clinically relevant CYP450 interactions [33].

Serotonergic Medications

Case reports suggest potential serotonin-related interactions between ginkgo and SSRIs (selective serotonin reuptake inhibitors), MAOIs (monoamine oxidase inhibitors), and triptans (migraine medications). These interactions are based on case reports rather than controlled studies, but caution is warranted [34].

Who Should Avoid Ginkgo or Use with Extreme Caution

• People taking warfarin, aspirin, or other blood thinners
• People with bleeding disorders or history of hemorrhagic stroke
• People with epilepsy or on anti-seizure medications
• People scheduled for surgery within 2 weeks
• Pregnant or breastfeeding women
• Couples actively trying to conceive
• People with diabetes on glucose-lowering medications (monitor closely if using)

Dietary Sources

Ginkgo biloba is not a nutrient obtained from the diet in the way that vitamins and minerals are. There are no meaningful dietary sources of the standardized flavonol glycosides and terpene lactones found in ginkgo leaf extracts [1][2].

Traditional Culinary Use of Ginkgo Seeds

Ginkgo seeds (also called ginkgo nuts or "bai guo" in Chinese cuisine) have been consumed in East Asian cooking for centuries, particularly in Chinese, Japanese, and Korean cuisines [2][3]. They are used in congee (rice porridge), chawanmushi (Japanese steamed egg custard), hotpot and stir-fry dishes, and various desserts and soups.

Important safety warning: Raw ginkgo seeds are toxic and can cause seizures, loss of consciousness, and death — particularly in children [2]. Even roasted ginkgo seeds can cause adverse reactions in some individuals. Ginkgo seeds contain a different chemical profile from ginkgo leaves and do not provide the same flavonol glycosides and terpene lactones studied in clinical trials. Eating ginkgo seeds is not a substitute for — and is not equivalent to — taking standardized ginkgo leaf extract supplements [1][2].

Ginkgo Leaf Tea

Ginkgo leaf tea is sold in some health food stores and traditional medicine markets. However, the concentration of active compounds in tea is far lower than in standardized extracts, and no clinical trials have tested ginkgo in tea form. The extraction efficiency of hot water steeping is substantially lower than the industrial extraction process used for supplements [1]. Additionally, ginkgo leaf tea may contain higher levels of ginkgolic acids than purified extracts [4][32].

References

1. ConsumerLab. "Ginkgo Biloba Supplements Review." Accessed 2025. https://www.consumerlab.com/reviews/ginkgo-supplements-memory-review/ginkgobiloba/

2. National Center for Complementary and Integrative Health (NCCIH). "Ginkgo." Updated February 2025. https://www.nccih.nih.gov/health/ginkgo

3. Czigle S, Nagy M, Mladenka P, et al. "Pharmacokinetic and pharmacodynamic herb-drug interactions — part I. Herbal medicines of the central nervous system." PeerJ. 2023;11:e16149. https://doi.org/10.7717/peerj.16149

4. Gawron-Gzella A, et al. "Ginkgo biloba L. — toxicological evaluation of standardized extract." Acta Poloniae Pharmaceutica. 2010;67(2):131-138.

5. Laws KR, Sweetnam H, Kondel TK. "Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis." Human Psychopharmacology. 2012;27(6):527-533. https://doi.org/10.1002/hup.2259

6. Chen J, et al. "Effects of a Ginkgo biloba and Cistanche tubulosa combination on cognitive function and biomarkers in healthy adults." Phytotherapy Research. 2024.

7. DeKosky ST, Williamson JD, Fitzpatrick AL, et al. "Ginkgo biloba for prevention of dementia: a randomized controlled trial." JAMA. 2008;300(19):2253-2262. https://doi.org/10.1001/jama.2008.683

8. Snitz BE, O'Meara ES, Carlson MC, et al. "Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial." JAMA. 2009;302(24):2663-2670. https://doi.org/10.1001/jama.2009.1913

9. Vellas B, Coley N, Ousset PJ, et al. "Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial." Lancet Neurology. 2012;11(10):851-859. https://doi.org/10.1016/S1474-4422(12)70206-5

10. Birks J, Grimley Evans J. "Ginkgo biloba for cognitive impairment and dementia." Cochrane Database of Systematic Reviews. 2007;(2):CD003120. https://doi.org/10.1002/14651858.CD003120.pub2

11. Liao Z, Cheng L, Li X, et al. "Meta-analysis of Ginkgo biloba preparation for the treatment of Alzheimer's disease." Clinical Neuropharmacology. 2020;43(4):93-99. https://doi.org/10.1097/WNF.0000000000000394

12. Kaschel R. "Specific memory effects of Ginkgo biloba extract EGb 761 in middle-aged healthy volunteers." Phytomedicine. 2011;18(14):1202-1207. https://doi.org/10.1016/j.phymed.2011.06.021

13. Beck SM, Ruge H, Schindler C, et al. "Effects of Ginkgo biloba extract EGb 761 on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment." Human Psychopharmacology. 2016;31(3):227-242. https://doi.org/10.1002/hup.2534

14. Crawford C, Boyd C, Deuster PA. "Dietary supplement ingredients for optimizing cognitive performance among healthy adults: a systematic review." Journal of Alternative and Complementary Medicine. 2021;27(11):940-958. https://doi.org/10.1089/acm.2021.0084

15. Haguenauer JP, Cantenot F, Koskas H, Pierart H. "Treatment of equilibrium disorders with Ginkgo biloba extract." Presse Medicale. 1986;15(31):1569-1572. https://pubmed.ncbi.nlm.nih.gov/2947174/

16. Cesarani A, Meloni F, Alpini D, et al. "Ginkgo biloba (EGb 761) in the treatment of equilibrium disorders." Advances in Therapy. 1998;15(5):291-304.

17. Sereda M, Xia J, El Refaie A, Hall DA, Hoare DJ. "Sound therapy (using amplification devices and/or sound generators) for tinnitus." Cochrane Database of Systematic Reviews. 2022. https://doi.org/10.1002/14651858.CD013094.pub2

18. Chauhan V, et al. "Effect of Ginkgo biloba and antioxidant supplementation on tinnitus: a randomized controlled trial." Journal of Audiology & Otology. 2023.

19. LaGuinn E, et al. "Ginkgo biloba for tinnitus." JAMA Otolaryngology — Head & Neck Surgery. 2025. https://doi.org/10.1001/jamaoto.2024.4568

20. Muir AH, Robb R, McLaren M, Daly F, Belch JJ. "The use of Ginkgo biloba in Raynaud's disease: a double-blind placebo-controlled trial." Vascular Medicine. 2002;7(4):265-267. https://doi.org/10.1191/1358863x02vm445oa

21. Numan AI, et al. "Effects of Ginkgo biloba extract (EGb 761) on pain in diabetic sensorimotor polyneuropathy." Tropical Journal of Pharmaceutical Research. 2016;15(5):1065-1073.

22. Price R, Smith D, Franklin G, et al. "Oral and topical treatment of painful diabetic polyneuropathy: Practice guideline update summary." Neurology. 2022;98(1):31-43. https://doi.org/10.1212/WNL.0000000000013038

23. Zhang W, Yan Y, Wu Y, et al. "Medicinal herbs for the treatment of anxiety: a systematic review and network meta-analysis." Pharmacological Research. 2022;179:106204. https://doi.org/10.1016/j.phrs.2022.106204

24. Hatfield J, Saad S, Housewright C. "Dietary supplements and bleeding." Proceedings (Baylor University, Medical Center). 2022;35(6):802-807. https://doi.org/10.1080/08998280.2022.2090011

25. Sugiura M. "Ginkgo biloba fruit-induced contact allergy." Global Journal of Allergy. 2016.

26. Chiu AE, et al. "Ginkgo biloba dermatitis." Journal of the American Academy of Dermatology. 2002.

27. Cohen PR. "Fixed drug eruption due to Ginkgo biloba with vinpocetine supplement." Journal of Clinical and Aesthetic Dermatology. 2017;10(11):44-46. https://pubmed.ncbi.nlm.nih.gov/29399268/

28. Yuste M, et al. "Stevens-Johnson syndrome/toxic epidermal necrolysis associated with Ginkgo biloba." Actas Dermosifiliograficas. 2005.

29. Hamilton K, et al. "Ginkgo biloba associated hyponatraemia." Internal Medicine Journal. 2019;49(9):1176-1178. https://doi.org/10.1111/imj.14413

30. Amir LH. "Medicines for breastfeeding women: a guide to the evidence." Australian Family Physician. 2011;40(9):684-690.

31. National Toxicology Program (NTP). "Toxicology and carcinogenesis studies of Ginkgo biloba extract in F344/N rats and B6C3F1/N mice." NTP Technical Report. 2013;578.

32. Gawron-Gzella A, Witkowska-Banaszczak E, Bylka W, et al. "Chemical composition and biological activities of Ginkgo biloba." Acta Poloniae Pharmaceutica. 2010;67(2):131-138.

33. Czigle S, Nagy M, Mladenka P, et al. "Pharmacokinetic and pharmacodynamic herb-drug interactions — part I." PeerJ. 2023;11:e16149. https://doi.org/10.7717/peerj.16149

34. Le TT, McGrath SR, Fasinu PS. "Herb-drug interactions in neuropsychiatric pharmacotherapy — a review of clinically relevant findings." Current Neuropharmacology. 2022;20(9):1736-1751. https://doi.org/10.2174/1570159X20666220210153842

35. Cave AE, Chang DH, Munch GW, et al. "A systematic review of the safety and efficacy on cognitive function of herbal and nutritional medicines in older adults." Systematic Reviews. 2023;12(1):143. https://doi.org/10.1186/s13643-023-02292-8

36. Liu Y, Xin H, Zhang Y, et al. "Leaves, seeds and exocarp of Ginkgo biloba L. (Ginkgoaceae): a comprehensive review of traditional uses, phytochemistry, pharmacology, resource utilization and toxicity." Journal of Ethnopharmacology. 2022;298:115645. https://doi.org/10.1016/j.jep.2022.115645